

We supplement your resource from strategic advice to hands-on delivery.


Want to accelerate your drug development process?
Book a free meeting with our regulatory experts to find a cost effective solution.
Welcome to Voisin Consulting Life Sciences
VCLS supports life science companies throughout product development, and engages in communication with regulators and payers. We partner with Biotech, Pharma and Medtech manufacturers to develop, register and launch innovative products in North American and European markets.
Through a network of partners, we also assist clients in Southeast Asia, Latin America, and a number of additional markets. We provide people-powered solutions to complement our clients’ in-house resources, from product development strategy, communication with regulators and payers up to market authorization and reimbursement.
How can VCLS help you?
REGULATORY STRATEGY
INTERACTION WITH AUTHORITIES
CLINICAL RESEARCH
SAFETY & PHARMACOVIGILANCE
Regulatory & Health Economics Expert Resources
Latest News & Events
-
BioTrinity 2018
Approaching the 12th consecutive year, the goal for BioTrinity is simple – to create an ideal network and partnering... -
Gene Therapy for Rare Disorders
Gene Therapy for Rare Disorders 2018 will focus exclusively on overcoming the late-stage commercial challenges drug... -
PEGS Boston 2018
PEGS: The Essential Protein Engineering Summit is one of the industry’s most preeminent events that inspires accelerated...
Latest Resources
-
Update on The Redistribution of UK’s portfolio of centrally authorised products
In preparation for Brexit, the 27 EU Member States, together with the European Medicines Agency (EMA), have reached a major... -
EU Downplays likelihood of UK staying in EMA after Brexit
In draft guidelines prepared by the President of the European Council, and published on 7 March 2018, the European Council has... -
Understand the Main CMC Challenges to Improve ATMP Development
Recent clinical successes in cell therapy and gene therapy have shown how fast this field is advancing. While the clinical...